Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.48 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.48 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.48 |
| ▸ | TLR4 | O00206 | 1/20 | 0.45 |
| ▸ | VEGFA | P15692 | 6/20 | 0.44 |
| ▸ | BMP2 | P12643 | 2/20 | 0.44 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.44 |
| ▸ | SHH | Q15465 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | SELP | P16109 | 2/20 | 0.41 |
| ▸ | B4GALT1 | P15291 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | IFNG | P01579 | 1/20 | 0.40 |
| ▸ | PF4 | P02776 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14010294 | 1.00 | MAPK1 (0.72) | MAPK1LGALS8LGALS3LGALS4TLR4 | |
| SCHEMBL7148649 | 0.86 | MAPK1 (0.77) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL11423444 | 0.86 | MAPK1 (0.77) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL7148656 | 0.86 | MAPK1 (0.77) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL4991663 | 0.85 | MAPK1 (0.50) | MAPK1TLR4ALDH1A1THRBAKT1 | |
| SCHEMBL4991659 | 0.85 | MAPK1 (0.50) | MAPK1TLR4ALDH1A1THRBAKT1 | |
| SCHEMBL4994061 | 0.85 | MAPK1 (0.50) | MAPK1TLR4ALDH1A1THRBAKT1 | |
| SCHEMBL14010283 | 0.85 | MAPK1 (0.50) | MAPK1TLR4ALDH1A1THRBAKT1 | |
| SCHEMBL4994069 | 0.85 | MAPK1 (0.50) | MAPK1TLR4ALDH1A1THRBAKT1 | |
| SCHEMBL14010258 | 0.85 | MAPK1 (0.50) | MAPK1TLR4ALDH1A1THRBAKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1553101-B1 | N-ACETYLGLUCOSAMINE DERIVATIVES AND USE THEREOF | KAO CORP (JP) | 2016-11-30 | — | — | EP | disclosed |
| US-20080293673-A1 | N-ACETYGLUCOSAMINE DERIVATIVES AND USE THEREOF | KAO CORPORATION | 2008-11-27 | — | — | US | disclosed |
| US-7393937-B2 | N-acetylglucosamine derivatives and use thereof | KAO CORPORATION (JP) | 2008-07-01 | — | — | US | disclosed |
| US-20060020127-A1 | N-acetylglucosamine derivatives and use thereof | KANEBO COSMETICS INC. (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1553101-A1 | N-ACETYLGLUCOSAMINE DERIVATIVES AND USE THEREOF | Kanebo Cosmetics Inc. (JP) | 2005-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020127-A1 | N-acetylglucosamine derivatives and use thereof | FUT6, B3GNT2, FUT5 | MAPK1 1512/4885LGALS8 173/4885LGALS3 208/4885 |
| US-20080293673-A1 | N-ACETYGLUCOSAMINE DERIVATIVES AND USE THEREOF | B3GNT2, FUT6, FUT5 | MAPK1 1506/4885LGALS8 178/4885LGALS3 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.